- Clinical Trials
- April 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- April 2024
- 70 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- January 2025
- 250 Pages
Global
From €4771EUR$4,999USD£3,997GBP
- Report
- August 2024
- 150 Pages
Global
From €2662EUR$2,789USD£2,230GBP
- Report
- February 2025
- 184 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- April 2024
- 185 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2024
- 70 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- July 2024
- 70 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- October 2024
- 200 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- May 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- July 2024
- 150 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- July 2024
- 100 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- February 2025
- 221 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- August 2024
- 178 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- July 2024
- 139 Pages
Global
From €2386EUR$2,500USD£1,999GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more